Related Experiment Video
Updated: Apr 23, 2026
02:09
Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
Published on: December 20, 2024
1.3K
Outcomes after early splenectomy for hematological disorders
Nirmal Gokarn1, Deepa Manwani, Patricia Friedmann
11 Division of General Surgery, Department of Surgery, Montefiore Medical Center , Bronx, New York.
Summary
Splenectomy in children with sickle cell disease is safe, regardless of age. This study found no increased complications in patients under five years old who underwent splenectomy compared to older patients.
Area of Science:
- Pediatric Hematology
- Surgical Outcomes
- Sickle Cell Disease Management
Background:
- Acute splenic sequestration crises are serious sickle cell disease complications.
- Historically, splenectomy was delayed due to sepsis concerns.
- Early splenectomy is increasingly considered, but safety data is limited.
Purpose of the Study:
- To compare splenectomy outcomes in pediatric sickle cell disease patients under five years old versus those five and older.
- To evaluate the safety and efficacy of early-life splenectomy.
Main Methods:
- Retrospective chart review of 30 pediatric sickle cell disease patients undergoing splenectomy.
- Comparison of intraoperative and postoperative outcomes between patients under five (Group 1) and those five or older (Group 2).
- Statistical analysis using Fisher's exact tests and nonparametric median tests.
Main Results:
- 18 patients were under five (Group 1), and 12 were five or older (Group 2).
- Laparoscopic splenectomy was common in both groups.
- Similar operative times, conversion rates, complication frequencies, and follow-up durations were observed.
- No portal vein thrombosis or postsplenectomy sepsis occurred in either group.
Conclusions:
- Splenectomy at a younger age (under five) showed no increased incidence of complications in this study.
- Further large, multicenter studies are necessary to confirm the safety of early-life splenectomy.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
2.9K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K
01:01Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K